SCHEMBL29022591

SCHEMBL29022591

O=S(=O)(NCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 1/20 0.67
▸ HTR7 P34969 4/20 0.62
▸ MEN1 O00255 3/20 0.57
▸ KMT2A Q03164 3/20 0.57
▸ GFER P55789 1/20 0.57
▸ KDM4E B2RXH2 1/20 0.55
▸ LMNA P02545 1/20 0.55
▸ GAA P10253 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ POLB P06746 1/20 0.55
▸ SIGMAR1 Q99720 5/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29022599 0.92 HTR1A (0.74) HTR1AHTR7MEN1KMT2A
SCHEMBL24069083 0.92 HTR1A (0.57) HTR1AHTR7KMT2AKDM4ELMNA
SCHEMBL29022589 0.85 HTR1A (0.64) HTR1AHTR7KMT2A
SCHEMBL25758490 0.84 HTR7 (0.72) HTR7MEN1KMT2AKDM4ELMNA
SCHEMBL1382312 0.80 HTR1A (1.00) HTR1AHTR7MEN1KMT2A
SCHEMBL25758479 0.80 KDM1A (0.58) HTR7KDM4ELMNAGAAMAPT
SCHEMBL1383722 0.79 HTR1A (0.82) HTR1AHTR7MEN1KMT2A
SCHEMBL25758458 0.78 SLC6A2 (0.61) MEN1KMT2AKDM4ELMNAGAA
SCHEMBL17374138 0.77 HTR7 (0.66) HTR1AHTR7KDM4ELMNASMN1; SMN2
SCHEMBL6568486 0.77 SIGMAR1 (0.72) HTR7KDM4ELMNAGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116157124-A Sulfonamide derivative and pharmaceutical composition for preventing or treating mental diseases containing the same as active ingredient 大邱庆北尖端医疗产业振兴财团 2023-05-23 — — CN claimed
CN-116157124-A Sulfonamide derivative and pharmaceutical composition for preventing or treating mental diseases containing the same as active ingredient 大邱庆北尖端医疗产业振兴财团 2023-05-23 — — CN disclosed
EP-4159718-A1 SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING MENTAL ILLNESS Daegu-Gyeongbuk Medical Innovation Foundation (KR) 2023-04-05 — — EP disclosed
Send feedback